Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

31.49USD
27 May 2015
Change (% chg)

$-0.12 (-0.38%)
Prev Close
$31.61
Open
$31.77
Day's High
$31.92
Day's Low
$31.28
Volume
471,465
Avg. Vol
649,457
52-wk High
$45.45
52-wk Low
$28.26

Search Stocks
Cohen Ron Options Exercised: 0
Trade Date: Monday, 19 Aug 2013 Price: 2.60
Title: Chief Executive Officer Shares Held: 478,868
Type Traded: Direct Net Change in Shares This Filing: 140,778

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 265
Total Shares Held: 46,961,475
3 Mo. Net Change: 1,742,420
# New Positions: 37
# Closed Positions: 22
# Increased Positions: 139
# Reduced Positions: 84
# Net Buyers: 55

Officers & Directors

Name Age Since Current Position

Ron Cohen

59 President,Chief Executive Officer, Director

Michael Rogers

55 2013 Chief Financial Officer

Andrew Blight

64 2004 Chief Scientific Officer

Jane Wasman

58 2012 President - International, General Counsel, Corporate Secretary

Enrique Carrazana

53 2011 Chief Medical Officer

Andrew Hindman

42 2014 Chief Business Development Officer

David Lawrence

57 2013 Chief - Business Operations

Lauren Sabella

54 2015 Chief Commercial Officer

Barry Greene

51 2007 Independent Director

Peder Jensen

60 2011 Independent Director

John Kelley

61 2008 Independent Director

Sandra Panem

68 1998 Independent Director

Lorin Randall

71 2006 Independent Director

Steven Rauscher

61 2005 Independent Director

Ian Smith

49 2007 Independent Director
Search Stocks